Respiratory symptoms and quality of life in asbestos-related diffuse pleural thickening and pleural plaques

Silvie Prazakova (Randwick, Australia), Silvie Prazakova, Alessandra Sandrini, Susan Miles, Paul Thomas, Anthony Johnson, Deborah Yates

Source: International Congress 2015 – Occupational and environmental cohort investigations and population studies
Session: Occupational and environmental cohort investigations and population studies
Session type: Thematic Poster Session
Number: 1166

Congress or journal article abstractE-poster

Abstract

Introduction: Pleural plaques (PPs) and diffuse pleural thickening (DPT) are common manifestations of asbestos exposure. The impact of PPs and DPT on quality of life (QoL) and respiratory symptoms has not been well defined. Aims: To evaluate respiratory symptoms, QoL and lung function in subjects with DPT and PPs compared with healthy controls. Methods: Individuals with PPs or DPT (classified according to the ATS statement on non-malignant asbestos-related disorders) and controls completed full lung function, the St George's Respiratory Questionnaire (SGRQ), SF-36 Health Survey and 6-minute walk test (MWT). Results: 73 subjects were recruited (24 PPs; 21 DPT; 28 controls). Results are shown in Table 1.

Table 1
 Controls n=28PPs n=24DPT n=21
Age (years)59 (46)69 (40)#70 (26)*
FEV1(%) (Mean(SD) 103.5 (12.6) 96.1 (11.5)# 80.1 (18.4)*^
FVC(%) (Mean(SD) 109.7 (12.5) 100.7 (10.4)# 87.9 (18.8)*^
FEV1 /FVC (%)(Mean(SD)74.9 (7.6) 72.9 (6.4) 71.0 (8.3)
SGRQ Symptom score9.9 (86.0) 18.4 (76.8) 25.3 (81.0)*
SGRQ Total score3.6 (66.4) 6.9 (58.0) 19.0 (84.4)*
SF-36 Mental Component Score (MCS)55.2 (36.4) 57.0 (29.9) 51.5 (36.3)
SF-36 Physical Component Score (PCS)55.2 (30.7) 48.7 (34.9)# 44.6 (38.4)*
6 MWT distance (%predicted) (Mean(SD) 100.4 (13.3) 92.9 (45.1) 90.2 (21.2)
 
In the DPT group, SGRQ symptoms score correlated inversely with FEV1(%)(r=-0.66, p<0.01) and FVC(%)(r=-0.53, p<0.05). SF-36 PCS correlated positively with FEV1(%) (r=0.72, p<0.01) and FVC(%) (r=0.69 p<0.01). Conclusions: Subjects with DPT and PPs have worse QoL compared with healthy individuals. However, the impact of PPs on QoL was smaller than DPT.
Median(range), #p<0.05 PPs v controls, *p<0.05 DPT v controls, ^p<0.05 DPT v PPs


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Silvie Prazakova (Randwick, Australia), Silvie Prazakova, Alessandra Sandrini, Susan Miles, Paul Thomas, Anthony Johnson, Deborah Yates. Respiratory symptoms and quality of life in asbestos-related diffuse pleural thickening and pleural plaques. Eur Respir J 2015; 46: Suppl. 59, 1166

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The influence of posttuberculosis pleural changes on pulmonary function and quality of life
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013

Quality indicators in pleural pathology
Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Year: 2018

Quality of life of idiopathic pulmonary fibrosis patients
Source: Eur Respir J 2001; 17: 954-961
Year: 2001



Quality of life in interstitial lung disease
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010

Quality of life in interstitial lung disease: Utility of the Kings brief interstitial lung disease questionairre at baseline
Source: International Congress 2015 – New insights into IIPs
Year: 2015

Health-related quality of life in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013


Quality of life measures in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013


Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016

Live patient and partner survey on pulmonary fibrosis
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014

An unusual case of plastic bronchitis
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013

Translation and preliminary validation of the KBILD QOL questionnaire to Spanish
Source: International Congress 2014 – ILDs 6
Year: 2014

The role of a pleural service in optimising pleural disease management
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014

Health-related quality of life in idiopathic pulmonary fibrosis (IPF): First results based on the European IPF registry
Source: International Congress 2014 – ILDs 1
Year: 2014

The association between objective CT measures of bronchiectasis and health-related quality of life in COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014

Co-morbid diagnoses of a current population of asbestos workers with diffuse pleural thickening (DPT)
Source: Annual Congress 2013 –Occupational respiratory diseases: obstructive, interstitial lung diseases and methods of diagnosis
Year: 2013


Quality of life of the patients followed for diffuse interstitial pneumonitis with  fibrosis
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018

Breathlessness in subjects with asbestos-related pleural plaques
Source: Eur Respir J 2002; 20: Suppl. 38, 127s
Year: 2002

Self-reported sleep quality in IPF
Source: International Congress 2014 – ILDs 5
Year: 2014

Impulse oscillometry measurements are correlated to quality of life in patients with pulmonary sarcoidosis
Source: International Congress 2014 – ILDs 1
Year: 2014

LATE-BREAKING ABSTRACT: Health-related quality of life of patients with idiopathic pulmonary fibrosis
Source: International Congress 2014 – Management of COPD in primary care
Year: 2014